<?xml version="1.0" encoding="UTF-8"?>
<p id="p0100">Ribavirin is an old antiviral drug used in the treatment of HCV for years, and that had a role in the treatment of SARS. As it causes dose-dependent hemolytic anemia, Ribavirin may potentiate the hematological toxicity of Interferon-beta and Tocilizumab. Ribavirin had no significant interaction with immunosuppressive drugs 
 <xref rid="b0285" ref-type="bibr">[57]</xref>.
</p>
